Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 228   

Articles published

SNY 54.70 -0.51 (-0.92%)
price chart
Sanofi, Regeneron Take Lead In Cholestrol Drug Race
Sanofi SA (ADR) (SNY) and Regeneron Pharmaceuticals Inc (REGN) are head-to-head with Amgen, Inc. (AMGN) to introduce the world's first PCSK9 inhibitor in the market.
Related articles »  
FDA Approves Sanofi's Breakthrough Gaucher Disease Drug
Sanofi's new drug will be a breakthrough, changing the way the disease is treated. Cerdelga, also known as eliglustat, is the first oral treatment, and is designed as a pill.
Related articles »  
Sanofi SA (ADR) (NYSE:SNY) Gets Clearance From The Competition ...
Sanofi SA (ADR) (NYSE:SNY) would acquire 20% stake in Apollo Sugar Clinics Ltd (ASCL) under this deal. Other than the 20% stake, SNY will also get certain management rights in ASCL, which is a subsidiary company of Apollo Health and Lifestyle.
Sanofi Raises Guidance After Second-Quarter Profit Jump
Sanofi SA (ADR) (SNY) beat the Street's earnings expectations for the second quarter of its fiscal year '14 (2QFY14, ended June 30); the company then raised its full-year guidance.
Related articles »  
Sanofi SA (ADR) (NYSE:SNY), MannKind (NASDAQ:MNKD) In Afrezza ...
Boston, MA 08/11/2014 (wallstreetpr) - French drug company Sanofi SA (ADR) (NYSE:SNY) and MannKind Corporation (NASDAQ:MNKD) have entered a global collaboration that involves developing and marketing of the inhaled insulin therapy, Afrezza, ...
FDA Approves Genzyme's Lumizyme For All Ages
Genzyme, a subsidiary of Sanofi SA (ADR) (SNY), announced last Friday, the US Food & Drug Administration's (FDA) approval of Lumizyme (Alglucosidase Alfa) for treating all patients suffering from infantile-onset Pompe disease, including those under the ...
Related articles »  
Three Stocks To Watch: Microsoft Corporation (NASDAQ:MSFT), Sanofi SA ...
Sanofi SA (ADR) (NYSE:SNY)'s President of North American Pharma unit, Anne Whitaker is possibly leaving the company to pursue ´┐Żanother´┐Ż opportunity.
Best Pharma Stocks Not In The U.S. [GlaxoSmithKline plc (ADR), AbbVie Inc ...
healthcare1 Marshall Hargrave: With tax inversions being one of the hottest topics in the merger and acquisition market these days, pharma stocks are in full focus.
Pfizer Inc. (NYSE:PFE) May See Lawsuit as Sanofi SA (NYSE:SNY ...
Sanofi Pasteur, the vaccines division of Sanofi SA (ADR) (NYSE:SNY) [Trend Analysis] reported that The New England Journal of Medicine published optimistic results from a large-scale, multi-center efficacy trial, which found that Fluzone High-Dose ...
Related articles »  
Today's Watch List: Banco Santander Brasil SA (ADR) (NYSE:BSBR), AbbVie Inc ...
French drug maker Sanofi SA (ADR) (NYSE:SNY) said Thursday its earnings soared in the second quarter thanks to lower accounting charges than a year earlier, and the company lifted it full-year profit forecast.
Related articles »